搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 30 天
时间不限
过去 1 小时
过去 24 小时
过去 7 天
按时间排序
按相关度排序
9 小时
Sagimet Soars: FDA Breakthrough Therapy Designation And Lancet Review Validate Denifanstat
Discover why Sagimet Biosciences' Denifanstat is a top contender in treating MASH, with FDA designation and strong financials ...
ENDPOINTS NEWS
9 小时
FDA won't take action against GLP-1 compounders as it rethinks tirzepatide shortage
The FDA clarified Thursday that it won't take action against GLP-1 compounders for certain violations while it reevaluates ...
Prescott eNews
21 小时
Pharmacy Leader Warns of Counterfeit Weight-Loss Drug Crisis – Inside Sources
Millions of Americans rely on a new class of medications to manage chronic conditions like diabetes and obesity, with ...
1 天
2 High-Flying Growth Stocks With Massive Upside Potential
The drugmaker's financial results are also impressive, spearheaded by tirzepatide, a therapy for diabetes and obesity that is ...
1 天
How Much Does Semaglutide Cost With and Without Insurance?
You’ve probably heard of the semaglutide brand names Ozempic®, Wegovy, and Rybelsus. You may have even heard about affordable options like compounded semaglutide.
nai500
1 天
礼来估值增长,投资者应该谨慎还是入手?
礼来是全球最有价值的医疗保健股票,市值超过8000亿美元。在过去12个月里,股价上涨了超过50%。尽管增长前景强劲,但投资者可能会对该股超过100倍的市盈率感到犹豫。
ConsumerAffairs
2 天
Compounding pharmacies can keep making Mounjaro and Zepbound copies
The U.S. Food and Drug Administration (FDA) is rethinking its decision to remove popular weight-loss and diabetes drugs from ...
ENDPOINTS NEWS
2 天
Compounding association to ask for clarity around tirzepatide's shortage ...
The Alliance for Pharmacy Compounding (APC) wants clarity around the FDA’s decision to reconsider tirzepatide’s removal from ...
Health.com
2 天
What the End of a Tirzepatide Shortage Would Mean for Access to Compounded Weight Loss Drugs
In response to a lawsuit, the FDA has said that it will reevaluate its previous decision to remove tirzepatide from its ...
Monthly Prescribing Reference
2 天
FDA Says Compounding Pharmacies Can Keep Making Weight-Loss Med Tirzepatide, for Now
On October 7, a compounding trade group filed a lawsuit challenging the agency's action, saying there was still a shortage of ...
2 天
3 Reasons Eli Lilly Stock Isn't Going to Run out of Steam Anytime Soon
Eli Lilly's valuation could look much more modest in the future, as its earnings should continue to grow at a high rate.
2 天
on MSN
Eli Lilly's tirzepatide is off the FDA's shortage list: What it means for patients
Eli Lilly's weight-loss drug is no longer on the Food and Drug Administration's drug shortage list. Compounding pharmacies ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈